{"transactions":[{"id":50,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":59,"kind":"person","name":"Holcomb John Bradley","position":1,"cik":"0002092279","reported_name":"Holcomb John Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T14:21:50.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":1233,"price":10.95,"value":13501.35,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":4691,"source":{"system":"sec-edgar","filing":"0001193125-26-379524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2092279/000119312526379524/ownership.xml","form_type":"4"}},{"id":753904,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":59,"kind":"person","name":"Holcomb John Bradley","position":1,"cik":"0002092279","reported_name":"Holcomb John Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:05:27.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":1091,"price":12.38,"value":13506.58,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":3458,"source":{"system":"sec-edgar","filing":"0001193125-26-253474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526253474/ownership.xml","form_type":"4"}},{"id":753903,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":59,"kind":"person","name":"Holcomb John Bradley","position":1,"cik":"0002092279","reported_name":"Holcomb John Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:05:27.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":1239,"price":10.9,"value":13505.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Due to an administrative error, the RSUs for Q1 2026 Board and committee compensation were not filed timely."}],"balance_after":2367,"source":{"system":"sec-edgar","filing":"0001193125-26-253474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526253474/ownership.xml","form_type":"4"}},{"id":796541,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":59,"kind":"person","name":"Holcomb John Bradley","position":1,"cik":"0002092279","reported_name":"Holcomb John Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-30T20:30:09.000Z","date":"2025-09-23","kind":"grant","planned":false,"acquired":true,"shares":4174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Options were awarded in accordance with the MiNK Therapeutics Inc. 2021 Amended and Restated Equity Incentive Plan on September 23, 2025 and will vest in three equal annual installments on each of September 23, 2026, 2027 and 2028 (provided Dr. Holcomb maintains a service relationship with the company through each such vesting date)."}],"balance_after":4174,"derivative":{"exercise_price":14.92,"expiration_date":"2035-09-23","underlying":"Common Stock","underlying_shares":4174},"source":{"system":"sec-edgar","filing":"0001193125-26-197482","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526197482/ownership.xml","form_type":"4"}},{"id":980915,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":59,"kind":"person","name":"Holcomb John Bradley","position":1,"cik":"0002092279","reported_name":"Holcomb John Bradley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T21:10:05.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":1128,"price":11.09,"value":12509.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation.  The RSUs will vest one month from the grant date."}],"balance_after":1128,"source":{"system":"sec-edgar","filing":"0001193125-25-306679","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312525306679/ownership.xml","form_type":"4"}}]}